Previous studies have revealed that TGF- β activates the PI3K-Akt pathway by inducing the expression of miR-216a/217 and miR-21 in kidney cancer cells and hepatoma cells [36, 37]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.